SurModics Correlations

SRDX Stock  USD 42.98  0.00  0.00%   
The current 90-days correlation between SurModics and Orthopediatrics Corp is 0.01 (i.e., Significant diversification). The correlation of SurModics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

SurModics Correlation With Market

Average diversification

The correlation between SurModics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SurModics and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in consumer price index.

Moving together with SurModics Stock

  0.69ALGN Align TechnologyPairCorr
  0.77CBLL CeriBell,PairCorr
  0.63CTSH Cognizant TechnologyPairCorr
  0.69LION Lionsgate Studios HoldingPairCorr

Moving against SurModics Stock

  0.74TLT Theralase TechnologiesPairCorr
  0.54OTC Ocumetics Technology CorpPairCorr
  0.45AHC Austco HealthcarePairCorr
  0.45NGMD NuGen Medical DevicesPairCorr
  0.44CSX Cleanspace HoldingsPairCorr
  0.38TOI Oncology InstitutePairCorr
  0.38TMCI Treace Medical ConceptsPairCorr
  0.36SMLR Semler ScientificPairCorr
  0.41KG Kestrel Group, Symbol ChangePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RXSTCBLL
XOMASMLR
CCRNTMCI
TCMDRXST
CCRNXOMA
CCRNSMLR
  

High negative correlations

TCMDTMCI
CCRNCBLL
CCRNRXST
TCMDCCRN
TCMDXOMA
RXSTTMCI

Risk-Adjusted Indicators

There is a big difference between SurModics Stock performing well and SurModics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SurModics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KIDS  1.94 (0.22) 0.00 (0.06) 0.00 
 4.68 
 13.88 
TMCI  3.11 (1.43) 0.00 (0.92) 0.00 
 5.46 
 33.84 
CBLL  3.01  0.87  0.26  0.54  2.84 
 7.04 
 16.78 
SMLR  5.12 (0.68) 0.00 (0.20) 0.00 
 9.78 
 44.64 
RXST  2.81  0.42  0.15  0.27  3.02 
 7.90 
 17.00 
XOMA  2.61 (0.53) 0.00 (1.28) 0.00 
 4.17 
 29.87 
CCRN  2.94 (0.78) 0.00 (0.27) 0.00 
 6.24 
 28.70 
LAB  2.53  0.08  0.03  0.12  3.19 
 4.69 
 14.73 
TCMD  2.59  1.25  0.76  3.20  0.54 
 7.40 
 43.88 
BVS  2.21  0.04  0.02  0.10  2.39 
 5.11 
 22.05 

SurModics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SurModics stock to make a market-neutral strategy. Peer analysis of SurModics could also be used in its relative valuation, which is a method of valuing SurModics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

SurModics Corporate Management

Charles OlsonSr. VP and General Manager of Medical DeviceProfile
Timothy ArensVP of Corporate Devel. and StrategyProfile
Joseph StichVP and General Manager of In-Vitro DiagnosticsProfile
Gordon JDGeneral LegalProfile
Gordon WeberGeneral LegalProfile